ArticleGynecologic oncology reports2022

Clinical use of PARP inhibitor in recurrent uterine leiomyosarcoma with presence of a somatic

Natalie Shammas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.